Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
VALERIO THERAPEUTICS | ALVIO | Euronext Paris +4 Other | 61,112 | 0.1098 EUR | Stock | |
VALERIO THERAPEUTICS | C4X | Deutsche Boerse AG | - | 0.0978 EUR | ||
VALERIO THERAPEUTICS | 0NWK | London S.E. | 23,237 | 0.7551 EUR | ||
VALERIO THERAPEUTICS | C4X | Börse Stuttgart | - | 0.1088 EUR | ||
VALERIO THERAPEUTICS | C4X | BOERSE MUENCHEN | - | 0.1014 EUR |
News (230)
Companies (1)
Valerio Therapeutics (formerly Onxeo) is a clinical-stage biotechnology company developing novel cancer drugs by targeting tumor DNA functions through unparalleled mechanisms of action in the highly sought-after field of DNA damage response (DDR). The com ...
Insiders
Valerio Battista is a businessperson who has been at the helm of 5 different companies. Mr. Battista holds the position of Chairman of Europacable Services Ltd. and Chief Executive Officer, Executive Director & GM at Prysmian SpA, Chief Executive Officer at Prysmian Kabel und Systeme GmbH and Chief Executive Officer of Prysmian Cabluri Si Sisteme SA (both are subsidiaries of Prysmian SpA). He is also on the board of Brembo SpA and Member-Council Board at International Electrotechnical Commission. Mr. Battista previously was CEO-Telecom Cables & Systems at Pirelli & C. SpA and Director-Steel Cord Business at Pirelli Tyre SpA (a subsidiary of Pirelli & C. SpA), Chairman at Prysmian Cavi e Sistemi Srl and Head-Engineering at UNO A Erre Italia SpA. Valerio Battista received an undergraduate degree from the University of Florence.
Paul Battista is the founder of Polarity.
Io Inc. He is currently the Chief Executive Officer, President, and Director of the company.
The company was founded in 2014.
No results for this search
- Stock Market
- Advanced search
- Valerio Battista